Viewing Study NCT01030432


Ignite Creation Date: 2025-12-24 @ 9:56 PM
Ignite Modification Date: 2025-12-31 @ 12:13 PM
Study NCT ID: NCT01030432
Status: COMPLETED
Last Update Posted: 2015-10-09
First Post: 2009-12-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module